Chapter/Section Purchase

1 Study Coverage
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market by Application
1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (2017-2028)
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region
2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Production by Region (2017-2022)
2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume & Value Estimates and Forecasts
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Estimates and Forecasts 2017-2028
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Estimates and Forecasts 2017-2028
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
3.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022)
3.4.2 Global Sales Diphtheria, Pertussis, and Tetanus Vaccine by Region (2023-2028)
3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region
3.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022)
3.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers
4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers
4.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2017-2022)
4.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine in 2021
4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers
4.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2017-2022)
4.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
4.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
5.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Type (2017-2022)
5.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Type (2023-2028)
5.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type
5.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Type (2017-2022)
5.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type
5.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022)
5.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
6.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Application (2017-2022)
6.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Application (2023-2028)
6.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application
6.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Application (2017-2022)
6.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application
6.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022)
6.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
7.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
7.1.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
7.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
7.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
7.2.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
7.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
7.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
7.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
8.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
8.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
8.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
8.2.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
8.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
8.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
8.3.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
9.1.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
9.1.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
9.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
9.2.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
9.2.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
9.3 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
9.3.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2028)
9.3.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
10.1.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
10.1.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
10.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
10.2.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
10.2.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
10.3 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
10.3.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
10.3.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
11.1.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
11.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
11.2.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
11.3 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
11.3.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Overview
12.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Johnson & Johnson Recent Developments
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Overview
12.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 GlaxoSmithKline Recent Developments
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Overview
12.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sanofi Recent Developments
12.4 Lanzhou Institute of Biological
12.4.1 Lanzhou Institute of Biological Corporation Information
12.4.2 Lanzhou Institute of Biological Overview
12.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Lanzhou Institute of Biological Recent Developments
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Overview
12.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Merck Recent Developments
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Overview
12.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Novartis Recent Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Corporation Information
12.7.2 AstraZeneca Overview
12.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 AstraZeneca Recent Developments
12.8 Emergent
12.8.1 Emergent Corporation Information
12.8.2 Emergent Overview
12.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Emergent Recent Developments
12.9 Astellas
12.9.1 Astellas Corporation Information
12.9.2 Astellas Overview
12.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Astellas Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Chain Analysis
13.2 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Diphtheria, Pertussis, and Tetanus Vaccine Production Mode & Process
13.4 Diphtheria, Pertussis, and Tetanus Vaccine Sales and Marketing
13.4.1 Diphtheria, Pertussis, and Tetanus Vaccine Sales Channels
13.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
13.5 Diphtheria, Pertussis, and Tetanus Vaccine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Trends
14.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
14.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
14.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
15 Key Finding in The Global Diphtheria, Pertussis, and Tetanus Vaccine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer